Ptc Therapeutics (PTCT) Enterprise Value (2012 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Enterprise Value of -$2.2 billion for Q2 2026, down 12.06% year-over-year from -$2.5 billion in Q2 2025, and down 17.79% quarter-over-quarter from -$1.9 billion in Q1 2026.
Ptc Therapeutics (PTCT) Enterprise Value (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Enterprise Value history runs 15 years deep, the most recent figure standing at -$2.2 billion for Q2 2026.
- In Q2 2026, Enterprise Value fell 12.06% year-over-year to -$2.2 billion; the TTM figure through Jun 2026 stood at -$2.2 billion (down 12.06% YoY), while the FY2025 annual figure was -$1.9 billion, down 70.69% from the prior year.
- Enterprise Value for Q2 2026 stood at -$2.2 billion, down from -$1.9 billion in the prior quarter.
- The five-year high for Enterprise Value was -$286.3 million in Q1 2023, with the low at -$2.2 billion in Q2 2026.
- The 5-year median for Enterprise Value is -$949.1 million (2024), against an average of -$1.1 billion.
- The sharpest annual moves came in 2022 and 2024: Enterprise Value jumped 66.77% in 2022, then tumbled 243.73% in 2024.
- Ptc Therapeutics' Enterprise Value stood at -$410.7 million in 2022, then plunged by 113.47% to -$876.7 million in 2023, then fell by 29.99% to -$1.1 billion in 2024, then sank by 70.69% to -$1.9 billion in 2025, then retreated by 14.58% to -$2.2 billion in 2026.
- Business Quant data shows PTCT's Enterprise Value at -$2.2 billion in Q2 2026, -$1.9 billion in Q1 2026, and -$1.9 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | -2.23 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.23 Bn |
| Mar 31, 2026 | -1.89 Bn |
| Dec 31, 2025 | -1.95 Bn |
| Sep 30, 2025 | -1.69 Bn |
| Jun 30, 2025 | -1.99 Bn |
| Mar 31, 2025 | -2.03 Bn |
| Dec 31, 2024 | -1.14 Bn |
| Sep 30, 2024 | -1.01 Bn |
| Jun 30, 2024 | -1.09 Bn |
| Mar 31, 2024 | -884.81 Mn |
| Dec 31, 2023 | -876.74 Mn |
| Sep 30, 2023 | -294.81 Mn |
| Jun 30, 2023 | -337.94 Mn |
| Mar 31, 2023 | -286.30 Mn |
| Dec 31, 2022 | -410.71 Mn |
| Sep 30, 2022 | -288.43 Mn |
| Jun 30, 2022 | -505.55 Mn |
| Mar 31, 2022 | -587.79 Mn |
| Dec 31, 2021 | -773.38 Mn |
| Sep 30, 2021 | -867.94 Mn |